Anti-CTLA4 re-induces the T-cell activation by antigen presenting cells whereas anti-PD1 inhibits the interaction leading to tumor escape between T-cells and tumor cells in the tumor microenvironment [1, 2]. The gene discussed is CTLA4; the disease is neoplasm.